MedPath

SIB-Norwegian Version, Validation and Reliability Study

Completed
Conditions
Dementia
Diagnostic Tests, Routine
Registration Number
NCT00449384
Lead Sponsor
Sykehuset Innlandet HF
Brief Summary

The purpose of this study is to validate and to test interrater reliability for the Norwgian version of Severe Impairment Battery (SIB).

Detailed Description

The study will include 60 persons with mild to severe dementia. To test the validation of SIB, we will interview the included persons with Severe Impairment Battery (SIB) and compare the results with Clinical Dementia Rating (CDV)reported by their nurses. To test interrater reliability 30 of the included persons will be interviewed with SIB by two different raters, and the two raters results will be compared.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • Dementia, mild to severe.
  • Nursing Home resident
Exclusion Criteria
  • No ability to write or read.
  • Physical handicapped, unable to use hands.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sykehuset Innlandet HF - Sanderud

🇳🇴

Ottestad, Oppland, Norway

© Copyright 2025. All Rights Reserved by MedPath